MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Illumina Operating Expenses 2011-2026 | ILMN
Annual Operating Expenses Illumina
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.69 B | 3.81 B | 3.28 B | 1.62 B | - | 1.43 B | 1.42 B | 1.08 B | 936 M | - | 783 M | 778 M | 510 M | 390 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.81 B | 390 M | 1.64 B |
Quarterly Operating Expenses Illumina
| 2025-Q3 | 2025-Q2 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 506 M | 481 M | 4 M | 2.36 B | 778 M | 820 M | 719 M | - | - | 1.35 B | 631 M | - | 1.32 B | 615 M | 571 M | - | 364 M | 332 M | 430 M | - | 340 M | 368 M | 380 M | - | 356 M | 348 M | 320 M | - | 301 M | 291 M | 316 M | - | 265 M | 262 M | 276 M | - | 247 M | 224 M | 199 M | - | 214 M | 200 M | 186 M | - | 164 M | 163 M | 264 M | - | 147 M | 150 M | 131 M | - | 120 M | 127 M | 119 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.36 B | 4 M | 423 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.14 | 0.44 % | $ 6.21 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 16.07 | 1.39 % | $ 173 M |  China |
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.99 B | $ 115.09 | 0.03 % | $ 35 B | USA |
 |
Interpace Biosciences
IDXG
|
20 M | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
411 M | $ 16.32 | 1.65 % | $ 870 M | USA |
 |
Medpace Holdings
MEDP
|
118 M | $ 498.22 | 0.95 % | $ 14.4 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Myriad Genetics
MYGN
|
964 M | $ 4.45 | 2.3 % | $ 412 M | USA |
 |
NeoGenomics
NEO
|
430 M | $ 7.87 | 2.34 % | $ 1.01 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
50.6 M | $ 1.4 | 2.19 % | $ 1.86 M | USA |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 23.05 | -0.35 % | $ 640 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
Senseonics Holdings
SENS
|
61.8 M | $ 6.62 | -0.9 % | $ 276 M | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 176.51 | 0.49 % | $ 8.75 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
181 M | $ 52.58 | -0.1 % | $ 2.67 B | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 190.99 | 0.73 % | $ 136 B | USA |
 |
Neuronetics
STIM
|
104 M | $ 1.37 | 1.11 % | $ 90.4 M | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 14.96 | 3.67 % | $ 452 M | USA |
 |
Thermo Fisher Scientific
TMO
|
7.15 B | $ 500.25 | 0.83 % | $ 189 B | USA |
 |
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.69 | -3.28 % | $ 61.9 M |  Irlanda |
 |
Guardant Health
GH
|
226 M | $ 79.27 | 0.85 % | $ 9.94 B | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
116 M | $ 48.44 | 1.11 % | $ 2.9 B | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 2.73 | 1.49 % | $ 88.6 K | USA |
 |
Biomerica
BMRA
|
5.64 M | $ 2.1 | -2.1 % | $ 4.82 M | USA |
 |
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 28.26 | -0.18 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 107.45 | 0.59 % | $ 8.86 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 261.12 | 0.07 % | $ 21.7 B | USA |
 |
Natera
NTRA
|
258 M | $ 197.55 | 2.34 % | $ 19.4 B | USA |
 |
Celcuity
CELC
|
172 M | $ 118.08 | 0.8 % | $ 5.52 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 80.41 | -0.23 % | $ 5.43 B | USA |
 |
Waters Corporation
WAT
|
687 M | $ 318.26 | -0.54 % | $ 19 B | USA |